company

LUMIBIRD MEDICAL NORDICS AS

1396 BILLINGSTAD

Return on Equity
15,92 %
Current Ratio
2,45
Debt-to-Equity Ratio
0,01
Key figures (NOK)2022
Revenue6 316 000
Net Income331 000
Total Assets3 537 000
Total Equity2 079 000
Income (NOK)2022
Revenue6 316 000
Expenditure5 891 000
Operating Profit424 000
Financial Income14 000
Financial Costs14 000
Financial Balance0
Earnings Before Tax425 000
Tax93 000
Net Income331 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets3 537 000
Total Assets3 537 000
Total Retained Equity0
Total Equity2 079 000
Total Long-Term Debt18 000
Total Current Debt1 441 000
Total Equity and Debt3 537 000
Cash flow (NOK)2022
Sales Income6 316 000
Other Income0
Revenue6 316 000
Cost of Goods Sold3 009 000
Salary Costs267 000
Depreciation7 000
Impairment0
Expenditure5 891 000
Operating Profit424 000
Financial Income14 000
Financial Costs14 000
Financial Balance0
Dividends0
Net Income331 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank3 261 000
Total Current Assets3 537 000
Total Assets3 537 000
Total Equity2 079 000
Short-Term Group Debt0
Total Long-Term Debt18 000
Creditors1 139 000
Unpaid Taxes110 000
Dividends0
Other Current Debt94 000
Total Current Debt1 441 000
Total Equity and Debt3 537 000
Financial indicators2022
Return on Equity15,92 %
Debt-to-Equity Ratio0,01
Operating Profit Margin6,71 %
Current Ratio2,45
Quick Ratio2,45
Equity Ratio0,59
Gross Profit Margin52,36 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English